Skeletal muscle relaxants for the treatment of myofascial pelvic pain and high tone pelvic floor disorders.

IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Current Opinion in Obstetrics & Gynecology Pub Date : 2023-08-01 DOI:10.1097/GCO.0000000000000894
Virginia Flatow, Jean Uy-Kroh, Erin T Carey, Charles Ascher-Walsh, Susan Khalil
{"title":"Skeletal muscle relaxants for the treatment of myofascial pelvic pain and high tone pelvic floor disorders.","authors":"Virginia Flatow,&nbsp;Jean Uy-Kroh,&nbsp;Erin T Carey,&nbsp;Charles Ascher-Walsh,&nbsp;Susan Khalil","doi":"10.1097/GCO.0000000000000894","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Chronic pelvic main is a complex process that includes many causes. In gynecology, the treatment of myofascial pelvic pain and high tone pelvic floor disorders can be managed with skeletal muscle relaxants for select clinical indications. A review of skeletal muscle relaxants will be included for gynecologic indications.</p><p><strong>Recent findings: </strong>There are limited studies on vaginal skeletal muscle relaxants, but there can be oral forms used for chronic myofascial pelvic pain. They function as antispastic, antispasmodic, and combination of the two modes of action. Diazepam is the most studied for myofascial pelvic pain in both oral and vaginal formulations. Its use can be combined with multimodal management to optimize outcomes. Other medications have limitations due to dependency and limited studies that demonstrate improvement in pain scales.</p><p><strong>Summary: </strong>Skeletal muscle relaxants have limited high quality studies for chronic myofascial pelvic pain. Their use can be combined with multimodal options to improve clinical outcomes. Additional studies are needed for vaginal preparations and evaluation of safety and clinical efficacy for patient reported outcomes measures in patients living with chronic myofascial pelvic pain.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":"35 4","pages":"311-315"},"PeriodicalIF":2.2000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Obstetrics & Gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/GCO.0000000000000894","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: Chronic pelvic main is a complex process that includes many causes. In gynecology, the treatment of myofascial pelvic pain and high tone pelvic floor disorders can be managed with skeletal muscle relaxants for select clinical indications. A review of skeletal muscle relaxants will be included for gynecologic indications.

Recent findings: There are limited studies on vaginal skeletal muscle relaxants, but there can be oral forms used for chronic myofascial pelvic pain. They function as antispastic, antispasmodic, and combination of the two modes of action. Diazepam is the most studied for myofascial pelvic pain in both oral and vaginal formulations. Its use can be combined with multimodal management to optimize outcomes. Other medications have limitations due to dependency and limited studies that demonstrate improvement in pain scales.

Summary: Skeletal muscle relaxants have limited high quality studies for chronic myofascial pelvic pain. Their use can be combined with multimodal options to improve clinical outcomes. Additional studies are needed for vaginal preparations and evaluation of safety and clinical efficacy for patient reported outcomes measures in patients living with chronic myofascial pelvic pain.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
骨骼肌松弛剂用于治疗骨盆肌筋膜疼痛和高音调盆底疾病。
综述目的:慢性盆腔炎是一个复杂的过程,包括许多原因。在妇科,肌筋膜盆腔疼痛和高音调盆底疾病的治疗可以用骨骼肌松弛剂治疗选定的临床适应症。骨骼肌松弛剂的审查将包括妇科适应症。最近发现:关于阴道骨骼肌松弛剂的研究有限,但可以口服形式用于慢性肌筋膜盆腔疼痛。它们的作用有抗痉挛、抗痉挛和两种作用方式的结合。地西泮是研究最多的肌筋膜盆腔疼痛在口服和阴道配方。它的使用可以与多模式管理相结合,以优化结果。其他药物由于依赖性和有限的研究证明疼痛程度的改善而有局限性。总结:骨骼肌松弛剂治疗慢性肌筋膜盆腔疼痛的高质量研究有限。它们的使用可与多模式选择相结合,以改善临床结果。对于患有慢性骨盆肌筋膜疼痛的患者,需要进一步的研究来进行阴道准备,以及评估其安全性和临床疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
104
审稿时长
6-12 weeks
期刊介绍: ​​​​​​​Current Opinion in Obstetrics and Gynecology is a bimonthly publication offering a unique and wide ranging perspective on the key developments in the field. Each issue features hand-picked review articles from our team of expert editors. With eleven disciplines published across the year – including reproductive endocrinology, gynecologic cancer and fertility– every issue also contains annotated references detailing the merits of the most important papers.
期刊最新文献
Access to maternity care: challenges and solutions for improving equity across US communities. Contemporary uses of "lethal" or "life limiting" terminology in perinatal research. Rho(D) immune globulin shortage and fetal Rh(D) screening with cell-free DNA. State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025. Sleep disturbance and menopause.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1